Ultrasound Imaging Of Ovarian And Adnexal Lesions

Overview

About this study

The overall goal of this pilot study is to evaluate the potential of UMI to enhance diagnostic accuracy for ovarian and adnexal lesions.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female patients aged ≥18 years; scheduled for surgery for ovarian or adnexal lesions.

 Exclusion Criteria:

  • Prior surgical removal of ovarian or adnexal lesions; undergoing neoadjuvant chemotherapy or targeted systemic therapy; or vulnerable populations, including prisoners, adults lacking capacity to consent, and pregnant women (our study coordinator will ask participants if they are pregnant; if uncertain, a urine pregnancy test will be offered at no cost).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/22/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen

Open for enrollment

Contact information:

Hanarica Pol

(507) 422-5118

pol.hanarica@mayo.edu

More information

Publications

Publications are currently not available